Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Breast Neoplasms 217Neoplasms 196Carcinoma, Non-Small-Cell Lung 94Colorectal Neoplasms 92Prostatic Neoplasms 79Lung Neoplasms 74Multiple Myeloma 49Head and Neck Neoplasms 48Neoplasm Metastasis 46Melanoma 46Pancreatic Neoplasms 44Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 35Brain Neoplasms 35Squamous Cell Carcinoma of Head and Neck 34Ovarian Neoplasms 32Glioblastoma 30Uterine Cervical Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Sarcoma 27Glioma 27Lymphoma, Non-Hodgkin 26Lymphoma 26Stomach Neoplasms 25Carcinoma, Renal Cell 25Lymphoma, Follicular 24Colonic Neoplasms 24Motor Activity 22Esophageal Neoplasms 22

Interventions

pembrolizumab 1omega-N-Methylarginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × DNA Repair-Deficiency Disorders × 90 days × Clear all
NCT03236935 2026-04-09

Phase Ib of L-NMMA and Pembrolizumab

The Methodist Hospital Research Institute

Phase 1 Completed
12 enrolled 15 charts
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡